Industry: Machinery & Equipment
Published Date: 2024-01-12
Pages: 91 Pages
Report ld: 2207412
Request Sample
Customized Report
The global BioPharma Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for BioPharma Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharma Service.
MARKET SEGMENTATION
REPORT SCOPE
The BioPharma Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BioPharma Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioPharma Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioPharma Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BioPharma Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Raw Material
1.2.3 In-Process and Product
1.2.4 Finished Pharmaceutical
1.2.5 Others
1.3 Market by Application
1.3.1 Global BioPharma Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Analytical Testing
1.3.3 Drug Development Service
1.3.4 Drug Packaging and Delivery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioPharma Service Market Perspective (2019-2030)
2.2 BioPharma Service Growth Trends by Region
2.2.1 Global BioPharma Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 BioPharma Service Historic Market Size by Region (2019-2024)
2.2.3 BioPharma Service Forecasted Market Size by Region (2025-2030)
2.3 BioPharma Service Market Dynamics
2.3.1 BioPharma Service Industry Trends
2.3.2 BioPharma Service Market Drivers
2.3.3 BioPharma Service Market Challenges
2.3.4 BioPharma Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top BioPharma Service Players by Revenue
3.1.1 Global Top BioPharma Service Players by Revenue (2019-2024)
3.1.2 Global BioPharma Service Revenue Market Share by Players (2019-2024)
3.2 Global BioPharma Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by BioPharma Service Revenue
3.4 Global BioPharma Service Market Concentration Ratio
3.4.1 Global BioPharma Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioPharma Service Revenue in 2023
3.5 BioPharma Service Key Players Head office and Area Served
3.6 Key Players BioPharma Service Product Solution and Service
3.7 Date of Enter into BioPharma Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 BioPharma Service Breakdown Data by Type
4.1 Global BioPharma Service Historic Market Size by Type (2019-2024)
4.2 Global BioPharma Service Forecasted Market Size by Type (2025-2030)
5 BioPharma Service Breakdown Data by Application
5.1 Global BioPharma Service Historic Market Size by Application (2019-2024)
5.2 Global BioPharma Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America BioPharma Service Market Size (2019-2030)
6.2 North America BioPharma Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America BioPharma Service Market Size by Country (2019-2024)
6.4 North America BioPharma Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe BioPharma Service Market Size (2019-2030)
7.2 Europe BioPharma Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe BioPharma Service Market Size by Country (2019-2024)
7.4 Europe BioPharma Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Service Market Size (2019-2030)
8.2 Asia-Pacific BioPharma Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific BioPharma Service Market Size by Region (2019-2024)
8.4 Asia-Pacific BioPharma Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America BioPharma Service Market Size (2019-2030)
9.2 Latin America BioPharma Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America BioPharma Service Market Size by Country (2019-2024)
9.4 Latin America BioPharma Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Service Market Size (2019-2030)
10.2 Middle East & Africa BioPharma Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa BioPharma Service Market Size by Country (2019-2024)
10.4 Middle East & Africa BioPharma Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Detail
11.1.2 Eurofins Business Overview
11.1.3 Eurofins BioPharma Service Introduction
11.1.4 Eurofins Revenue in BioPharma Service Business (2019-2024)
11.1.5 Eurofins Recent Development
11.2 Pace Analytical Services
11.2.1 Pace Analytical Services Company Detail
11.2.2 Pace Analytical Services Business Overview
11.2.3 Pace Analytical Services BioPharma Service Introduction
11.2.4 Pace Analytical Services Revenue in BioPharma Service Business (2019-2024)
11.2.5 Pace Analytical Services Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent BioPharma Service Introduction
11.3.4 Catalent Revenue in BioPharma Service Business (2019-2024)
11.3.5 Catalent Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo BioPharma Service Introduction
11.4.4 Envigo Revenue in BioPharma Service Business (2019-2024)
11.4.5 Envigo Recent Development
11.5 PPD
11.5.1 PPD Company Detail
11.5.2 PPD Business Overview
11.5.3 PPD BioPharma Service Introduction
11.5.4 PPD Revenue in BioPharma Service Business (2019-2024)
11.5.5 PPD Recent Development
11.6 Element
11.6.1 Element Company Detail
11.6.2 Element Business Overview
11.6.3 Element BioPharma Service Introduction
11.6.4 Element Revenue in BioPharma Service Business (2019-2024)
11.6.5 Element Recent Development
11.7 ALS
11.7.1 ALS Company Detail
11.7.2 ALS Business Overview
11.7.3 ALS BioPharma Service Introduction
11.7.4 ALS Revenue in BioPharma Service Business (2019-2024)
11.7.5 ALS Recent Development
11.8 Intertek
11.8.1 Intertek Company Detail
11.8.2 Intertek Business Overview
11.8.3 Intertek BioPharma Service Introduction
11.8.4 Intertek Revenue in BioPharma Service Business (2019-2024)
11.8.5 Intertek Recent Development
11.9 SGS
11.9.1 SGS Company Detail
11.9.2 SGS Business Overview
11.9.3 SGS BioPharma Service Introduction
11.9.4 SGS Revenue in BioPharma Service Business (2019-2024)
11.9.5 SGS Recent Development
11.10 Boston Analytical
11.10.1 Boston Analytical Company Detail
11.10.2 Boston Analytical Business Overview
11.10.3 Boston Analytical BioPharma Service Introduction
11.10.4 Boston Analytical Revenue in BioPharma Service Business (2019-2024)
11.10.5 Boston Analytical Recent Development
11.11 EAG
11.11.1 EAG Company Detail
11.11.2 EAG Business Overview
11.11.3 EAG BioPharma Service Introduction
11.11.4 EAG Revenue in BioPharma Service Business (2019-2024)
11.11.5 EAG Recent Development
11.12 Maxxam
11.12.1 Maxxam Company Detail
11.12.2 Maxxam Business Overview
11.12.3 Maxxam BioPharma Service Introduction
11.12.4 Maxxam Revenue in BioPharma Service Business (2019-2024)
11.12.5 Maxxam Recent Development
11.13 ARL Bio Pharma
11.13.1 ARL Bio Pharma Company Detail
11.13.2 ARL Bio Pharma Business Overview
11.13.3 ARL Bio Pharma BioPharma Service Introduction
11.13.4 ARL Bio Pharma Revenue in BioPharma Service Business (2019-2024)
11.13.5 ARL Bio Pharma Recent Development
11.14 West Pharmaceutical
11.14.1 West Pharmaceutical Company Detail
11.14.2 West Pharmaceutical Business Overview
11.14.3 West Pharmaceutical BioPharma Service Introduction
11.14.4 West Pharmaceutical Revenue in BioPharma Service Business (2019-2024)
11.14.5 West Pharmaceutical Recent Development
11.15 BioScreen
11.15.1 BioScreen Company Detail
11.15.2 BioScreen Business Overview
11.15.3 BioScreen BioPharma Service Introduction
11.15.4 BioScreen Revenue in BioPharma Service Business (2019-2024)
11.15.5 BioScreen Recent Development
11.16 Microbac
11.16.1 Microbac Company Detail
11.16.2 Microbac Business Overview
11.16.3 Microbac BioPharma Service Introduction
11.16.4 Microbac Revenue in BioPharma Service Business (2019-2024)
11.16.5 Microbac Recent Development
11.17 RD Laboratories
11.17.1 RD Laboratories Company Detail
11.17.2 RD Laboratories Business Overview
11.17.3 RD Laboratories BioPharma Service Introduction
11.17.4 RD Laboratories Revenue in BioPharma Service Business (2019-2024)
11.17.5 RD Laboratories Recent Development
11.18 Analytical Lab Group
11.18.1 Analytical Lab Group Company Detail
11.18.2 Analytical Lab Group Business Overview
11.18.3 Analytical Lab Group BioPharma Service Introduction
11.18.4 Analytical Lab Group Revenue in BioPharma Service Business (2019-2024)
11.18.5 Analytical Lab Group Recent Development
11.19 Piramal Pharma Solutions
11.19.1 Piramal Pharma Solutions Company Detail
11.19.2 Piramal Pharma Solutions Business Overview
11.19.3 Piramal Pharma Solutions BioPharma Service Introduction
11.19.4 Piramal Pharma Solutions Revenue in BioPharma Service Business (2019-2024)
11.19.5 Piramal Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for BioPharma Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 135
USD 3950.00
(Single User License)
The global BioPharma Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 122
USD 2900.00
(Single User License)
The global BioPharma Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-21
Pages: 154
USD 4900.00
(Single User License)
The global market for BioPharma Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 125
USD 3950.00
(Single User License)
The global market for BioPharma Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Market Analysis and Insights: Global BioPharma Service Market
Published Date: 2024-04-11
Pages: 114
USD 4900.00
(Single User License)
The global market for BioPharma Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 138
USD 3950.00
(Single User License)
The global market for BioPharma Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 135
The global BioPharma Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 122
The global BioPharma Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-21
Pages: 154
The global market for BioPharma Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 125
The global market for BioPharma Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
Market Analysis and Insights: Global BioPharma Service Market
Published: 2024-04-11
Pages: 114
The global market for BioPharma Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 138
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now